Categorizing a prognostic variable: Review of methods, code for easy implementation and applications to decision-making about cancer treatments

Statistics in Medicine

Volumn 19, Issue 1, 2000, Pages 113-132

  Mazumdar, Madhu ^a   Glassman, Jill R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIOSTATISTICS; CANCER RISK; CANCER THERAPY; MEDICAL DECISION MAKING; MULTIVARIATE ANALYSIS; PROGNOSIS; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ANTINEOPLASTIC AGENTS; CHI-SQUARE DISTRIBUTION; HUMANS; LYMPHOMA; MALE; MODELS, STATISTICAL; NEOPLASMS; PROBABILITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0034650624     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O     Document Type: Article

References (23)

1. Gilewski, T., Norton, L. 'Breast cancer' in Kelley, W. N. (ed.), Disorders of Oncology and Hematology, Lippincott-Raven Publishers, Philadelphia, 1997, Chapter 221.
2. Altman, D. G., Lausen, B. and Sauerbrei, W. 'Dangers of using "optimal" cutpoints in the evaluation of prognostic factors', Journal of the National Cancer Institute, 86, (11), 829-835 (1994).
3. Miller, R. and Siegmund, D. 'Maximally selected chi square statistics', Biometrics, 38, 1011-1016 (1982).
4. Lausen, B. and Schumacher, M. 'Maximally selected rank statistics', Biometrics, 48, 73-85 (1992).
5. Lausen, B. and Schumacher, M. 'Evaluating the effect of optimized cutoff values in the assessment of prognostic factors', Computational Statistics & Data Analysis, 21, 307-326 (1996).
6. Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlof, B., Elmfeldt, D., Julius, S., Menard, J., Rahn, K. H., Wedel, H. and Westerling, S. 'Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principle results of the Hypertension Optimal Treatment (HOT) trial', Lancet, 351, 1755-1762 (1998).
7. S-PLUS for Windows Reference Manual, Vol. 1, version 3.1, Statistical Sciences, Inc., Seattle, WA, March, 1993.
8. Kaplan, E. L. and Meier, P. 'Nonparametric estimation from incomplete observation.' Journal of the American Statistical Association, 53, 457-481 (1958).
9. Heller, G. and Simonoff, J. S. 'Prediction in censored survival data: a comparison of the proportional hazards and linear regression models', Biometrics, 48, 101-115 (1992).
10. Mantel, N. 'Evaluation of survival data and two new rank order statistics arising in its consideration', Cancer Chemotherapy Reports, 50, 163-170 (1966).
11. Hilsenbeck, S. G. and Clark, G. M. 'Practical p-value adjustment for optimally selected cutpoints', Statistics in Medicine, 15, 103-112 (1996).
12. Moskowitz, C., Glassman, J., Wuest, D., Maslak, P., Reich, L., Gucciardo, A., Coady-Lyons, N., Zelenetz, A. and Nimer, S. 'Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma', Clinical Cancer Research, 4, 311-316 (1998).
13. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. and Hunstein, W. 'Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma', Blood, 83, (12), 3787-3794 (1994).
14. Bensinger, W., Appelbaum, F., Rowley, S., Storb, R., Sanders, J., Lilleby, K., Gooley, T., Demirer, T., Schiffman, K., Weaver, C., Clift, R., Chauncey, T., Klarnet, J., Montgomery, P., Petersdorf, S., Weiden, P., Witherspoon, R. and Buckner, C. 'Factors that influence collection and engraftment of autologous peripheral-blood stem cells', Journal of Clinical Oncology, 13, (10), 2547-2555 (1995).
15. Bender, J., Bik To, L., Williams, S. and Schwartzberg, L. 'Defining a therapeutic dose of peripheral blood stem cells', Journal of Haematotherapy, 1, 329-341 (1992).
16. Hohaus, S., Goldschmidt, H., Ehrhardt, R. and Haas, R. 'Successful autografting following myeloablative conditioning therapy with blood stem cells mobilized by chemotherapy plus rhG-CSF', Experimental Haematology, 21, 508-514 (1993).
17. Agresti, A. Categorical Data Analysis, Wiley, New York, 1990.
18. Herr, H. W., Scheinfeld, J., Puc, H. S., Heelan, R., Bajorin, D. F., Mencel, P., Bosl, G. J. and Motzer, R. J. 'Surgery for a post-chemotherapy residual mass in seminoma', Journal of Urology, 157, (3), 860-862 (1997).
19. Jones, B. M., Newlands, E. S., Begent, R. H., Rustin, G. J., Bagshawe, K. D., Johnson, A. G. and Reynolds, K. W. 'The role of abdominal surgery in the treatment of advanced testicular germ cell tumors', British Journal of Surgery, 69, (1), 4-6 (1982).
20. Motzer, R., Bosl, G., Heelan, R., Fair, W., Whitmore, W., Sogani, P., Herr, H., and Morse, M. 'Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy', Journal of Clinical Oncology, 5, 1064-1070 (1987).
21. Puc, H., Heelan, R., Mazumdar, M., Herr, H., Scheinfeld, J., Vlamis, V., Bajorin, D., Bosl, G., Mencel, P. and Motzer, R. 'Management of residual mass in advanced seminoma: results and recommendations from the Memorial Sloan-Kettering Cancer Center', Journal of Clinical Oncology, 14, 454-460 (1996).
22. Lausen, B., Sauerbrei, W. and Schumacher, M. 'Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales', in Dirschedl P and Ostermann R. (ed.), Computational Statistics, Physica-Verlag Heidelberg, Germany, 1994.
23. Lausen, B., Kersting, M. and Schoch, G. 'The regression tree method and its application in nutritional epidemiology', Informatik, Biometric und Epidemiologie in medizin und biologie, 28, (1), 1-13 (1997).